Floristem CEO and President Yaki Yanai and Tnuva Group Chairman Haim Gavrieli celebrated the joint venture for the development, production and marketing of cultured food announced last January
The biotechnology company Floristem Therapeutics Inc. and the food manufacturer Tnuva participated last Monday in the official NASDAQ ceremony to mark the closing of the New York Trading Day. Representatives of the companies celebrated the joint venture for the development, production and marketing of cultured food announced last January. – A walker in New York and on the NASDAQ website, during which Floristem CEO and president Yaki Yanai and Tnuva Group chairman Haim Gavrieli greeted and rang the bell that officially announces the closing of the trading day.
The joint venture will be based on Floristem’s unique multi-cell technology and will adapt it to the civilized food world. It is a unique and groundbreaking technological platform to support the development and production of a variety of cultured food products from various sources including beef, chicken, fish and milk. In the first phase, the joint venture, headed by Eyal Rosenthal, will develop cultured meat products.
1 View the gallery
Representatives of Floristem and Tnuva close the trading day on NASDAQ
Under the agreement, Floristem will license its technology to grow a variety of cells as a raw material, and Tnuva will provide the R&D envelope for the development of the final products to the consumer, and later the distribution and marketing of the products that will be sold and distributed in Israel and around the world.
Floristem is currently one of the world’s most advanced companies in cell production, and this is the first time it has implemented its technology in the field of podtech. Tnuva is the largest food group in Israel, which leads the milk substitutes market, and is the largest producer and pioneer of R&D in the field, for 18 years. The cooperation between Floristem and Tnuva will enable the production of the next generation of protein substitutes.
The substitute meat market is one of the fastest growing in the world. Floristem has the ability to design and develop technologies and processes for the production of cells in commercial quantities, based on a unique three-dimensional (3D) platform that simulates the natural environment of the cell and allows it to multiply.
“We are excited to celebrate the important collaboration between Floristem and Tnuva at NASDAQ,” said Yaki Yanai, CEO and President of Floristem. “Over the years, Floristem has developed one of the most advanced technology platforms for cell growth, through which we can deliver extracellular products at high masses and economically efficiently. Over the past year, we have focused our strategy on leveraging our technology and experience through partnerships and manufacturing extracellular products for a variety of industries “We are proud of our cooperation with a market leader such as the Tnuva Group, which brings with it 96 years of experience in the field of food and innovation.”
Haim Gavrieli, Chairman of the Tnuva Group: “I am pleased to note the groundbreaking collaboration between Floristem and the Tnuva Group. Through the collaboration, Tnuva is fulfilling its vision to become a market leader in a number of markets, including the food tech market and protein substitutes. We believe that this step will allow us to continue to be the leading food company in Israel and at the same time to expand globally. I am sure that together, the two companies will carry out a revolution in the field of civilized food. “
Zami Aberman, Chairman of Floristem: “While Floristem continues its innovative work in the pharma field, we are also initiating new collaborations aimed at leveraging our technological cell platform and promoting other industries. Tnuva is the ideal partner for us in the field of food tech and we believe the collaboration between the two companies It will lead to the production of high-quality, accessible and discounted cultured meat for consumers. “
Eyal Melis, CEO of the Tnuva Group: “The Tnuva Group has decades of experience in developing and marketing innovative products for the Israeli market, it is a leader in the field of protein substitutes in Israel and recently brought its experience to international markets. We chose to partner with Floristem because we believe it has some of the most advanced cell production technology in the world. We expect that the cooperation between the two companies will lead to a revolution in the field of cultured food and will open the next generation of protein substitutes. “